이벤트

모두 보기
    Join BIOCYTOGEN at CABS 2025 BioPacific Conference Exhibitor

    Join BIOCYTOGEN at CABS 2025 BioPacific Conference Exhibitor

    September 13, 2025
    ~에 공유:

    Biocytogen is thrilled to be participating as an exhibitor at the 2025 BioPacific Conference in San Francisco, CA on September 13th! This premier event brings together scientists, executives, and biopharma professionals to explore the latest breakthroughs and future directions in life sciences. We look forward to engaging discussions, new connections, and sharing our latest innovations in antibody discovery and gene-editing technology. See you this fall in the Bay Area!

    What is the (CABS) 2025 BioPacific Conference Exhibitor? 

    The BioPacific Conference is the annual flagship event of the CABS. The event mission is to bring scientists, executives and biopharmaceutical professionals from the Pacific Rim countries together to discuss the latest advances in the world of life sciences, the unprecedented challenges and promises facing the industry, and the breathtaking developments and opportunities in Asia/Pacific countries.

    Event Overview  

    Date: Saturday, Sept 13, 2025 | 8:00am – 8:00pm PT

    Venue: South San Francisco Convention Center. 255 S Airport Blvd, South San Francisco, CA 94080

    Event Schedule

    For more event information, please refer to BioSpecific Conference.

    About BIOCYTOGEN

    Biocytogen is a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies. Founded on gene editing technology, Biocytogen leverages genetically engineered proprietary RenMice® platforms for fully human monoclonal antibody discovery, and has established a sub-brand, RenBiologics™, to explore global partnerships for an off-the-shelf library of >400,000 fully human antibody sequences against approximately 1000 targets for worldwide collaboration. Biocytogen pioneered the generation of drug target knock-in humanized models for preclinical research, and currently provides a few thousand off-the-shelf animal and cell models under the company's sub-brand, BioMice™, along with preclinical pharmacology and gene-editing services for clients worldwide. Headquartered in Beijing, Biocytogen has branches in China (Haimen Jiangsu, Shanghai), USA(Boston, San Francisco), and Germany (Heidelberg).

    We look forward to seeing you in South San Francisco!